Catalyst Pharmaceuticals wants to increase the maximum recommended daily dosage of Firdapse (amifampridine), its Lambert-Eaton myasthenic syndrome (LEMS) treatment, to 100 mg. Plans are underway to ask the U.S. Food and Drug Administration (FDA) to approve the new dose, the company announced in a press release detailing its…
Read more
Last week, much of the northeastern United States was hunkered down for yet another nor’easter. As snow fell on our northern neighbors, here in the South, we were enjoying spring-like weather. Many of the local schools are out for spring break. My back porch is full of flowers blooming red…
For a woman with cancer complicated by Lambert-Eaton myasthenic syndrome (LEMS), treating the cancer with an immune checkpoint inhibitor did not worsen her LEMS, according to a report. Her case suggests that, at least in some instances, immune checkpoint inhibitors may be a treatment option for cancer patients who…
Columnist Lori Dunham offers words of hope and encouragement to those facing a diagnosis of Lambert-Eaton myasthenic syndrome.
Visit the Lambert-Eaton News forums to connect with others in the LEMS community.
Want to stay up to date on all the latest on LEMS? Click the link below to find more news and information.
Becoming educated and informed about LEMS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your LEMS journey.
There is no cure for LEMS yet, but there are treatments that can help manage the disease. Learn more about current therapeutic approaches here.
Get regular updates to your inbox.